• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配体/细胞穿透肽修饰的聚合物纳米胶束经鼻腔-脑递药系统用于颅内神经胶质瘤

Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.

机构信息

School of Pharmaceutical Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.

School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan.

出版信息

Eur J Pharm Biopharm. 2020 Jul;152:85-94. doi: 10.1016/j.ejpb.2020.05.001. Epub 2020 May 5.

DOI:10.1016/j.ejpb.2020.05.001
PMID:32387702
Abstract

We previously developed a nose-to-brain delivery system using poly(ethylene glycol)-polycaprolactone block polymeric micelles modified by a cell-penetrating peptide, Tat (PEG-PCL-Tat). This system showed excellent delivery of the anti-cancer drug camptothecin to the brain and improved therapeutic efficacy in a brain tumor model. However, improvements are necessary to selectively deliver drugs to tumor sites once they enter the brain, and avoid toxic side effects to normal brain tissue. In this study, to develop tumor-selective novel polymeric micelles, mixed micelles consisting of Tat-conjugated polymer micelles and stearoyl-modified bombesin (Bom/PEG-PCL-Tat) were designed. The GRPR selectivity, cellular uptake, and cytotoxicity in C6 glioma cells as well as the intracerebral drug distribution and therapeutic efficacy of Bom/PEG-PCL-Tat mixed micelles after intranasal administration in C6 glioma orthotropic grafted rats were evaluated. Selective cellular uptake and marked cytotoxic effects against GRPR-expressing C6 glioma cells were observed, as well as C6 tumor tissue-specific accumulation in vivo. Rats treated with camptothecin subsequent to a brain tumor graft survived longer when the drug was delivered by Bom/PEG-PCL-Tat mixed micelles than by PEG-PCL-Tat micelles.

摘要

我们之前开发了一种使用穿透肽 Tat(PEG-PCL-Tat)修饰的聚乙二醇-聚己内酯嵌段聚合物胶束的鼻内递药系统。该系统显示出了将抗癌药物喜树碱递送到大脑中的优异效果,并在脑肿瘤模型中提高了治疗效果。然而,有必要进行改进,以便在药物进入大脑后选择性地将药物递送到肿瘤部位,并避免对正常脑组织产生毒性副作用。在这项研究中,为了开发肿瘤选择性的新型聚合物胶束,设计了由 Tat 修饰的聚合物胶束和硬脂酰化的脑肠肽(Bom/PEG-PCL-Tat)组成的混合胶束。评估了 Bom/PEG-PCL-Tat 混合胶束在 C6 神经胶质瘤细胞中的 GRPR 选择性、细胞摄取和细胞毒性,以及在 C6 神经胶质瘤原位移植大鼠经鼻给药后的脑内药物分布和治疗效果。观察到了对表达 GRPR 的 C6 神经胶质瘤细胞的选择性细胞摄取和明显的细胞毒性作用,以及体内 C6 肿瘤组织的特异性蓄积。在脑肿瘤移植后,用 Bom/PEG-PCL-Tat 混合胶束递送喜树碱的大鼠比用 PEG-PCL-Tat 胶束递送的大鼠存活时间更长。

相似文献

1
Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas.配体/细胞穿透肽修饰的聚合物纳米胶束经鼻腔-脑递药系统用于颅内神经胶质瘤
Eur J Pharm Biopharm. 2020 Jul;152:85-94. doi: 10.1016/j.ejpb.2020.05.001. Epub 2020 May 5.
2
Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.细胞穿透肽修饰的嵌段共聚物胶束通过鼻内给药促进脑内直接递送。
Pharm Res. 2011 Sep;28(9):2130-9. doi: 10.1007/s11095-011-0440-7. Epub 2011 Apr 16.
3
Prolongation of life in rats with malignant glioma by intranasal siRNA/drug codelivery to the brain with cell-penetrating peptide-modified micelles.通过细胞穿透肽修饰的胶束经鼻将小干扰RNA/药物共递送至脑延长恶性神经胶质瘤大鼠的生存期
Mol Pharm. 2014 May 5;11(5):1471-8. doi: 10.1021/mp400644e. Epub 2014 Apr 16.
4
Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.利用脑靶向给药和细胞穿透肽修饰的纳米胶束联合给药递送至脑内的 siRNA。
Biomaterials. 2013 Dec;34(36):9220-6. doi: 10.1016/j.biomaterials.2013.08.036. Epub 2013 Aug 28.
5
Cell-Penetrating Peptide Modified PEG-PLA Micelles for Efficient PTX Delivery.细胞穿透肽修饰的 PEG-PLA 胶束用于高效 PTX 递送。
Int J Mol Sci. 2020 Mar 9;21(5):1856. doi: 10.3390/ijms21051856.
6
Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.载顺铂的 PCL 纳米粒的制备及经鼻腔给药的评价。
Drug Deliv. 2016 Sep;23(7):2144-2153. doi: 10.3109/10717544.2014.948643. Epub 2014 Dec 29.
7
TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.基于TAT肽的胶束系统,用于将抗癌药物潜在地主动靶向酸性实体瘤。
J Control Release. 2007 Apr 2;118(2):216-24. doi: 10.1016/j.jconrel.2006.12.008. Epub 2006 Dec 13.
8
Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.聚乙二醇外壳可脱落的 TAT 修饰的核交联纳米胶束:TAT 增强的细胞摄取和溶酶体 pH 触发的阿霉素释放。
Colloids Surf B Biointerfaces. 2020 Apr;188:110772. doi: 10.1016/j.colsurfb.2020.110772. Epub 2020 Jan 20.
9
Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.载喜树碱的tat 修饰的纳米胶束经鼻腔给药治疗颅内脑肿瘤。
Pharmaceuticals (Basel). 2012 Oct 15;5(10):1092-102. doi: 10.3390/ph5101092.
10
Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.负载白消安并设计用于多模态成像的可生物降解聚合物纳米载体的生物分布
J Nanobiotechnology. 2016 Dec 19;14(1):82. doi: 10.1186/s12951-016-0239-0.

引用本文的文献

1
Cell-penetrating peptides as facilitators of cargo-specific nanocarrier-based drug delivery.细胞穿透肽作为基于纳米载体的货物特异性药物递送的促进剂。
Nanoscale. 2025 Aug 26. doi: 10.1039/d5nr00617a.
2
Brain Delivery Strategies for Biomacromolecular Drugs: Intranasal Administration.生物大分子药物的脑递送策略:鼻内给药
Int J Nanomedicine. 2025 May 22;20:6463-6487. doi: 10.2147/IJN.S520768. eCollection 2025.
3
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting.纳米载体用于鼻脑靶向给药的创新与最新进展综述
Des Monomers Polym. 2025 Feb 10;28(1):7-29. doi: 10.1080/15685551.2025.2464132. eCollection 2025.
4
The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases.聚合物纳米颗粒作为药物递送载体在神经退行性疾病细胞中的应用。
Cell Prolif. 2025 Aug;58(8):e13804. doi: 10.1111/cpr.13804. Epub 2025 Feb 11.
5
Combined Strategies for Nanodrugs Noninvasively Overcoming the Blood-Brain Barrier and Actively Targeting Glioma Lesions.纳米药物非侵入性跨越血脑屏障并主动靶向胶质瘤病灶的联合策略
Biomater Res. 2025 Feb 5;29:0133. doi: 10.34133/bmr.0133. eCollection 2025.
6
Current Non-Metal Nanoparticle-Based Therapeutic Approaches for Glioblastoma Treatment.当前基于非金属纳米颗粒的胶质母细胞瘤治疗方法
Biomedicines. 2024 Aug 11;12(8):1822. doi: 10.3390/biomedicines12081822.
7
Ribavirin in Modern Antitumor Therapy: Prospects for Intranasal Administration.现代抗肿瘤治疗中的利巴韦林:鼻内给药的前景。
Curr Drug Deliv. 2024 Aug 26. doi: 10.2174/0115672018305548240614113451.
8
Glioma and Peptidergic Systems: Oncogenic and Anticancer Peptides.神经胶质瘤与肽系统:致癌肽与抑癌肽。
Int J Mol Sci. 2024 Jul 22;25(14):7990. doi: 10.3390/ijms25147990.
9
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.肽搭乘用于神经胶质瘤中纳米系统的发展。
ACS Nano. 2024 Jul 2;18(26):16359-16394. doi: 10.1021/acsnano.4c01790. Epub 2024 Jun 11.
10
Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasound.改善血脑屏障通透性的策略共识综述,包括聚焦超声。
Neuro Oncol. 2024 Sep 5;26(9):1545-1556. doi: 10.1093/neuonc/noae087.